HK Stock Market Move | SUNMI TECH-W(06810) rises more than 12%, ranking first in global Android terminal BIoT market share, significantly optimizing company profitability.
Smartmi Technology (06810) surged over 12% during trading hours, as of the time of publication, it has risen by 9.55%, trading at 82 Hong Kong dollars, with a turnover of 35.53 million Hong Kong dollars.
Sunmi Technology-W (06810) rose more than 12% during trading hours, up 9.55% as of the time of writing, to 82 Hong Kong dollars, with a trading volume of 35.5363 million Hong Kong dollars.
It is reported that Sunmi Technology is currently the world's largest provider of BIoT solutions, with the largest enterprise application market globally, providing real-time services to developers and merchants in over 200 countries and regions. The company first launched the industry's first PaaS platform "Sunmi SuperApp", a low-code modular platform consisting of over 1000 modules covering more than 20 verticals. According to data from Shenzhen Insight Consulting, based on 2024 revenue estimates, Sunmi Technology holds over 10% of the global Android BIoT market share, ranking first globally. The market size of the Android BIoT in 2024 is approximately 32 billion RMB, expected to reach 92 billion RMB by 2029.
Financial data shows that from 2023 to 2025, the company's revenue steadily increased from 3.071 billion RMB to 3.812 billion RMB; the gross profit margin increased from 26.7% to 31.3%, demonstrating a strong premium ability brought by high value-added business. At the same time, the company achieved positive operating cash flow for three consecutive years, reaching 210 million RMB in 2025. Guotou Securities International previously pointed out that overall, Sunmi Technology is the global leader in the Android commercial IoT field, benefiting from high industry growth, with technological, customer, and global barriers, stable financial growth, and clear long-term growth logic.
Related Articles

HK Stock Market Move | CISI FIN(06058) surged nearly 8% with year-on-year net profit after tax increasing by over 50% last year. Its China core asset fund has continued to perform exceptionally well.

A 40% premium! GlaxoSmithKline plc Sponsored ADR (GSK.US) plans to acquire Nuvalent (NUVL.US) for $10.6 billion, stepping up its presence in the cancer drug sector.

Yamato: Increased visibility of AI monetization in Chinese technology stocks, prefer TENCENT (00700) and others.
HK Stock Market Move | CISI FIN(06058) surged nearly 8% with year-on-year net profit after tax increasing by over 50% last year. Its China core asset fund has continued to perform exceptionally well.

A 40% premium! GlaxoSmithKline plc Sponsored ADR (GSK.US) plans to acquire Nuvalent (NUVL.US) for $10.6 billion, stepping up its presence in the cancer drug sector.

Yamato: Increased visibility of AI monetization in Chinese technology stocks, prefer TENCENT (00700) and others.






